Study types
- article 40
- book-chapter 5
- book 4
- review 3
- letter 2
Condition tags
- endometriosis 35
- mesh:D004715 25
- adenomyosis 8
- mesh:D017699 6
- die_deep_infiltrating 4
- mesh:D004412 3
- dysmenorrhea 2
- bowel_endometriosis 2
- infertility 1
- bladder_endometriosis 1
Top journals
Frequent coauthors
Aim: to review evolution of hormonal therapy for endometriosis with a particular focus on a role of GnRH antagonists in modern clinical practice. The paper will highlight mechanisms of action, efficacy and safety of these drugs, as well as …
BACKGROUND: Endometriosis is a benign, hormone-dependent, chronic inflammatory gynecological disease accompanied by cyclic and acyclic pelvic pain and other complaints. The long lists of research recommendations in the AWMF guideline (Burgh…
Abstract BackgroundEndometriosis is a benign, hormone-dependent, chronic inflammatory gynecological disease accompanied by cyclic and acyclic pelvic pain and other complaints. The long lists of research recommendations in the AWMF guideline…
Introduction: The aim of this study was to compare the subjective theories of illness in patients with fibroids and patients with endometriosis, and to identify potential factors influencing them. Methodology: Participating patients were re…
Abstract Aims The aim of this official guideline published and coordinated by the German Society of Gynaecology and Obstetrics (DGGG) in cooperation with the Austrian Society for Gynaecology and Obstetrics (OEGGG) and the Swiss Society for …
OBJECTIVE: Migraine, endometriosis, and the comorbidity of both are frequent pain disorders of special relevance for women. The neuropeptide calcitonin gene-related peptide (CGRP) is critically involved in migraine, and circumstantial evide…
Trotz guter Erfahrungen in der klinischen Praxis gibt es aktuell auch Zweifel am Nutzen der Anwendung von kombinierten östrogenhaltigen Kontrazeptiva (KOK) bei Dysmenorrhö, wenn diese ein Symptom der Endometriose ist 1.
A 27‐year‐old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well. The patient reported less side effects compared to the oral…
, Z1022, 5 ,
STUDY OBJECTIVE: To study the safety and efficacy of dienogest 2 mg in adolescents with suspected endometriosis. DESIGN: A 52-week, open-label, single-arm study. SETTING: In 21 study centers, in 6 European countries. PARTICIPANTS: Adoles…
status: Published
Purpose This retrospective study aimed to describe patient characteristics of women with deep infiltrating endometriosis [DIE] affecting the bowel and bladder treated in a referral center in Germany, and to calculate direct costs during inp…
status: Published
The idea of quality improvement in the management of endometriosis has been brought to attention throughout Europe. This - first and foremost - includes the implementation of centers specialized in treating endometriosis. This leads to qual…